ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,038Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 29

$680K Total Retail Price of All Prescriptions

Rank: 7 out of 29

303 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 10,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 433 428 1 3
MIRTAZAPINE 402 393 2 13
LEVOTHYROXINE SODIUM 356 350 3 1
GABAPENTIN 349 322 4 10
POTASSIUM CHLORIDE 343 330 5 6
LISINOPRIL 334 307 6 2
WARFARIN SODIUM 318 308 7 14
CITALOPRAM HBR 268 250 8 11
METOPROLOL TARTRATE 267 245 9 15
AMLODIPINE BESYLATE 262 244 10 5
OMEPRAZOLE 260 212 11 8
NAMENDA 258 256 12 12
SIMVASTATIN 226 208 13 4
ATENOLOL 139 137 14 23
LANTUS SOLOSTAR 136 117 15 92
CARVEDILOL 134 118 16 27
RISPERIDONE 133 133 17 49
QUETIAPINE FUMARATE 131 128 18 32
DONEPEZIL HCL 126 126 19 9
HYDROCODONE-ACETAMINOPHEN 122 97 S3 20 7
TAMSULOSIN HCL 122 122 20 31
SERTRALINE HCL 114 114 22 17
CYMBALTA 112 94 23 29
DIVALPROEX SODIUM 98 94 24 45
LANTUS 96 78 25 39
DIVALPROEX SODIUM ER 95 77 26 99
METFORMIN HCL 94 71 27 19
TRAMADOL HCL 88 88 28 24
EXELON 86 71 29 38
DIOVAN 81 80 30 35
HYDRALAZINE HCL 81 68 30 56
SODIUM CHLORIDE 80 78 32 166
METOCLOPRAMIDE HCL 77 44 33 133
LIDODERM 76 46 34 139
DIGOXIN 76 75 34 34
ABILIFY 73 63 36 106
LATANOPROST 72 72 37 98
MELOXICAM 72 70 37 36
ISOSORBIDE DINITRATE 71 71 39 116
HYDROCHLOROTHIAZIDE 69 53 40 20
BACLOFEN 69 44 40 80
LOSARTAN POTASSIUM 68 68 42 28
LEVETIRACETAM 68 67 42 77
VENLAFAXINE HCL ER 67 67 44 87
METOPROLOL SUCCINATE 67 66 44 16
CLONIDINE HCL 67 65 44 53
CARBIDOPA-LEVODOPA 65 65 47 42
CEPHALEXIN 63 61 48 89
TRAZODONE HCL 62 39 49 22
AGGRENOX 58 52 50 79
IPRATROPIUM-ALBUTEROL 53 53 51 58
LEVOFLOXACIN 53 51 51 60
SEROQUEL 52 48 53 71
PANTOPRAZOLE SODIUM 50 50 54 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.